The discovery that miR-126 regulates insulin signaling provides novel insights into the molecular basis underlying mitochondrial dysfunction-derived pathogenesis of insulin resistance, and implicates miRNAs in metabolic diseases. This evidence concerns the gene INS and metabolic disease.